Parametrica Management’s Century Therapeutics IPSC Stock Holding History

Parametrica Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$47.6K	Hold	27,840	–	–	0.03%	26
2026 Q2	$68.2K	Hold	27,840	–	–	0.05%	19
2026 Q1	$62.9K	Hold	27,840	–	–	0.07%	19
2025 Q4	$27.7K	Hold	27,840	–	–	0.04%	21
2025 Q3	$13.9K	Hold	27,840	–	–	0.02%	23
2025 Q2	$15.6K	Hold	27,840	–	–	0.03%	27
2025 Q1	$13.3K	Hold	27,840	–	–	0.02%	23
2024 Q4	$28.1K	Hold	27,840	–	–	0.04%	65
2024 Q3	$47.6K	Hold	27,840	–	–	0.06%	62
2024 Q2	$71K	Hold	27,840	–	–	0.09%	20
2024 Q1	$116K	Hold	27,840	–	–	0.17%	22
2023 Q4	$92.4K	Hold	27,840	–	–	0.15%	26
2023 Q3	$55.7K	Hold	27,840	–	–	0.09%	29
2023 Q2	$88K	Hold	27,840	–	–	0.17%	26
2023 Q1	$96.6K	Hold	27,840	–	–	0.17%	24
2022 Q4	$143K	Hold	27,840	–	–	0.29%	35
2022 Q3	$275K	Sell	27,840 -1,015	-4%	-$10.7K	0.56%	40
2022 Q2	$241K	Buy	+28,855	New	+$283K	0.26%	103
2022 Q1	–	Sell	-28,855	Closed	-$459K	–	241
2021 Q4	$459K	Buy	28,855 +100	+0.3%	+$1.88K	0.46%	36
2021 Q3	$723K	Buy	+28,755	New	+$778K	0.54%	39

Other funds holding IPSC

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Parametrica Management's IPSC Position: Q3 2026 in Review

Parametrica Management held its Century Therapeutics (IPSC) position steady in Q3 2026 at 27,840 shares worth $47.6K. The position accounts for 0.03% of the portfolio, ranked #26.

Parametrica Management first reported a position in IPSC in Q3 2021 and has held it in 20 quarters since. The position peaked at $723K in Q3 2021. 11 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

Parametrica Management held 27,840 shares of Century Therapeutics worth $47.6K as of Q3 2026.
Parametrica Management left its Century Therapeutics share count unchanged in Q3 2026.
Century Therapeutics made up 0.03% of Parametrica Management's portfolio in Q3 2026, its #26 holding.
Parametrica Management first reported a position in Century Therapeutics in Q3 2021 and has held it in 20 quarters since.
Parametrica Management's Century Therapeutics position peaked at $723K in Q3 2021.
11 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Parametrica Management's 13F filing for Q3 2026, filed 27 Oct 2026.